Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Cancer chemoprevention strategies include modulating drug-metabolizing enzymes to enhance carcinogen elimination.
• Phase 2 enzyme inducers, like dithiolethiones, show promise in inhibiting tumorigenesis and modulating carcinogen metabolism.
• The Keap1-Nrf2 complex is identified as a crucial molecular target for these chemopreventive inducers.

Purpose of the Study:

• To review the role of Nrf2 in regulating phase 2 and antioxidative genes.
• To examine the molecular mechanisms of dithiolethiones acting on the Keap1-Nrf2 pathway.
• To understand the contribution of Nrf2-regulated genes to the protective effects of chemopreventive inducers.

Main Methods:

• Literature review focusing on the Keap1-Nrf2 pathway and its role in cancer chemoprevention.
• Analysis of studies investigating dithiolethiones and their interaction with the Keap1-Nrf2 complex.
• Examination of genetic studies, including Nrf2-deficient mice, to assess chemopreventive efficacy.

Main Results:

• Nrf2, a transcription factor, translocates to the nucleus upon Keap1-Nrf2 complex dissociation, activating phase 2 detoxifying enzymes.
• Dithiolethiones and other inducers modulate the Keap1-Nrf2 pathway, leading to the upregulation of cytoprotective genes.
• Nrf2-dependent gene expression is critical for the chemopreventive efficacy of inducers against carcinogens.

Conclusions:

• The Keap1-Nrf2 pathway is a central regulator of cellular defense mechanisms against electrophilic and oxidative stress.
• Targeting the Keap1-Nrf2 pathway with small molecules offers a promising strategy for cancer chemoprevention.
• Understanding this pathway provides insights into coordinated mammalian defense systems and potential therapeutic interventions.